A post-hoc subgroup analysis of outcomes in the first phase III clinical study of edaravone (MCI-186) in amyotrophic lateral sclerosis

THE EDARAVONE (MCI-186) ALS 16 STUDY GROUP

Research output: Contribution to journal › Article › peer-review

37 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A post-hoc subgroup analysis of outcomes in the first phase III clinical study of edaravone (MCI-186) in amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences